These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17102907)
1. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells. Huang Q; Pu P; Xia Z; You Y J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907 [TBL] [Abstract][Full Text] [Related]
2. Wild Type p53 gene sensitizes rat C6 glioma cells to HSV-TK/ACV treatment in vitro and in vivo. Huang Q; Xia Z; You Y; Pu P Pathol Oncol Res; 2010 Dec; 16(4):509-14. PubMed ID: 20084481 [TBL] [Abstract][Full Text] [Related]
3. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
4. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
5. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells. Li LQ; Shen F; Xu XY; Zhang H; Yang XF; Liu WG ScientificWorldJournal; 2013; 2013():951343. PubMed ID: 23533367 [TBL] [Abstract][Full Text] [Related]
6. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
7. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of HSV-tk suicide gene therapy driven by the Grp78 stress-inducible promoter in esophagogastric junction and gastric adenocarcinomas. Azatian A; Yu H; Dai W; Schneiders FI; Botelho NK; Lord RV J Gastrointest Surg; 2009 Jun; 13(6):1044-51. PubMed ID: 19277794 [TBL] [Abstract][Full Text] [Related]
9. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models. Chen Y; Huang H; Yao C; Su F; Guan W; Yan S; Ni Z Cancer Med; 2016 Sep; 5(9):2477-86. PubMed ID: 27366865 [TBL] [Abstract][Full Text] [Related]
11. [Suicide gene therapy for glioma using HSV-tk/GCV system]. Xu L; Ge K; Zheng Z Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):353-7. PubMed ID: 10920915 [TBL] [Abstract][Full Text] [Related]
12. Iron Oxide Nanoparticles Promote Cx43-Overexpression of Mesenchymal Stem Cells for Efficient Suicide Gene Therapy during Glioma Treatment. Li A; Zhang T; Huang T; Lin R; Mu J; Su Y; Sun H; Jiang X; Wu H; Xu D; Cao H; Sun X; Ling D; Gao J Theranostics; 2021; 11(17):8254-8269. PubMed ID: 34373740 [No Abstract] [Full Text] [Related]
13. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
14. Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53. Liu X; Wang S; Guo X; Wei F; Yin J; Zang Y; Li N; Chen D Oncotarget; 2016 Apr; 7(14):18896-905. PubMed ID: 26934443 [TBL] [Abstract][Full Text] [Related]
15. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line]. Huang H; Wang A Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726 [TBL] [Abstract][Full Text] [Related]
16. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353 [TBL] [Abstract][Full Text] [Related]
17. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]. Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864 [TBL] [Abstract][Full Text] [Related]
18. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells. Mori K; Iwata J; Miyazaki M; Osada H; Tange Y; Yamamoto T; Aiko Y; Tamura M; Shiroishi T Neurol Med Chir (Tokyo); 2010; 50(7):545-53. PubMed ID: 20671379 [TBL] [Abstract][Full Text] [Related]
20. [Anti-glioma activity of treatment by bone marrow stromal cells transfected with HSV-tk in the rat]. Li CH; Jiao BH Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):171-5. PubMed ID: 17649630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]